The HIVACAR project seeks to provide a therapeutic alternative to the current treatment of HIV, lifelong combined antiretroviral therapy (cART). By focusing on an innovative strategy based on the patient's immune system, this project aims to achieve a functional cure for HIV. This could revolutionize HIV management on a global scale, offering a more accessible, safe, and affordable treatment for people living with HIV.
Clinical Trials and Development Phases
The HIVACAR project is currently in phase I/IIa of clinical trials, where new therapeutic strategies are being tested. This process allows for the evaluation of the safety and efficacy of treatments in a rigorous clinical setting. The goal is to establish a safe and accessible treatment for people living with HIV.
The Objectives of the HIVACAR Project
Title: An Innovative Scientific Project to Combat HIV
The potential side effects of medications.
The risk of developing resistance to current treatments.
Lifelong adherence is necessary to maintain the effectiveness of the treatment.
Partnerships with the Community
Title: Collaboration with People Living with HIV in Europe
The project is supported by the European AIDS Treatment Group (EATG), which represents the voice of people living with HIV in Europe. This ensures that the perspectives and needs of the community are taken into account throughout the project's development, thus ensuring a patient-centered approach.
